argenx SE (ARGX)
444.71
-1.21
(-0.27%)
USD |
NASDAQ |
Jun 27, 16:00
444.71
0.00 (0.00%)
After-Hours: 20:00
argenx Gross Profit (Quarterly): 357.82M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 357.82M |
December 31, 2023 | 367.36M |
September 30, 2023 | 293.79M |
June 30, 2023 | 246.53M |
March 31, 2023 | 200.80M |
December 31, 2022 | 161.38M |
September 30, 2022 | 127.72M |
Date | Value |
---|---|
June 30, 2022 | 70.18M |
March 31, 2022 | 22.04M |
December 31, 2021 | 26.02M |
September 30, 2021 | 0.857M |
June 30, 2021 | 312.24M |
March 31, 2021 | 158.16M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.857M
Minimum
Sep 2021
367.36M
Maximum
Dec 2023
180.38M
Average
161.38M
Median
Dec 2022
Gross Profit (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | -- |
Koninklijke Philips NV | 1.971B |
Qiagen NV | 290.99M |
Trinity Biotech PLC | 5.522M |
uniQure NV | -0.741M |